This inventor holds 5 USPTO granted patents and 4 published patent applications. Top assignees: The City University of New York, Columbia University. Active years: 2008-2017.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2008-2017
Title: Linda Saxe Einbond: Innovator in Cancer Treatment
Introduction
Linda Saxe Einbond is a prominent inventor based in Crestwood, NY (US). She has made significant contributions to the field of cancer treatment through her innovative research and patented inventions. With a total of 5 patents, her work focuses on developing methods and compositions that offer low toxicity and high bioavailability for treating cancer.
Latest Patents
Einbond's latest patents include groundbreaking inventions such as "Methods and compositions for the treatment of cancer." This invention provides compositions that are designed to treat cancer while minimizing toxicity. Another notable patent is "Triterpene glycoside and triterpene compositions and methods of using same." This invention employs various strategies to enhance the bioavailability of triterpene glycosides and triterpenes, including a covalent approach with polyethylene glycol and a formulation approach using non-covalent encapsulation in antibody-targeted pol(DL-lactic acid) nanoparticles.
Career Highlights
Throughout her career, Linda Saxe Einbond has worked with esteemed institutions such as the City University of New York and Columbia University. Her research has been pivotal in advancing the understanding and treatment of cancer, showcasing her dedication to improving patient outcomes.
Collaborations
Einbond has collaborated with notable individuals in her field, including I Bernard Weinstein and Stephen Redenti. These partnerships have further enriched her research and contributed to her innovative work.
Conclusion
Linda Saxe Einbond stands out as a key figure in the realm of cancer treatment innovations. Her patents reflect her commitment to developing effective and safe therapeutic options for patients. Through her work, she continues to make a lasting impact on the medical community.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
